Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
carcinomacolorectal-cancerimmunotherapyrectal-cancer
colorectal cancer, rectal cancer, cemiplimab, fianlimab, regen7075, oxaliplatin, capecitabine, immunotherapy, anti-pd-1 (programmed death-ligand 1)(protein immune checkpoint), pd-l1 (programmed death-ligand 1)(protein immune checkpoint), adenocarcinoma, carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 856533
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.